Caring Brands, Inc. 8K

Caring Brands Inc. reported the issuance of five U.S. patents protecting its flagship Hair Enzyme Booster and Photocil platforms to support a licensing-focused commercialization strategy and noted its continued noncompliance with Nasdaq listing requirements amid an ongoing delisting appeal.

On August 6, 2026, Caring Brands Inc. announced that its commercial intellectual property portfolio now includes five issued U.S. patents covering its two principal product platforms, Hair Enzyme Booster and Photocil, which target large global dermatology and hair care markets; the company emphasized that these patents support a licensing-led commercialization strategy, ongoing strategic partner discussions including existing relationships such as Taisho Pharmaceutical, and a hybrid B2B and DTC go‑to‑market plan, while also reiterating that it remains out of compliance with Nasdaq’s stockholders’ equity requirement and is appealing a Nasdaq delisting determination with no assurance of regaining compliance or maintaining its listing.

Filing Facts

CIK

2020737

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-036419

Alert Tier

6